Vanoxerine Dihydrochloride 100mg 100mg | Purity Not Available
Adooq Bioscience
Vanoxerine (GBR-12909) is a piperazine derivative which is a potent and selective DRI.
More Information Supplier PageVanoxerine (GBR-12909) is a piperazine derivative which is a potent and selective DRI.
More Information Supplier PageVanoxerine (GBR-12909) is a piperazine derivative which is a potent and selective DRI.
More Information Supplier PagePhlorizin is a competitive inhibitor of SGLT1 and SGLT2; this reduces renal glucose transport, lowering the amount of glucose in the blood.
More Information Supplier PagePhlorizin is a competitive inhibitor of SGLT1 and SGLT2; this reduces renal glucose transport, lowering the amount of glucose in the blood.
More Information Supplier PagePhlorizin is a competitive inhibitor of SGLT1 and SGLT2; this reduces renal glucose transport, lowering the amount of glucose in the blood.
More Information Supplier PagePhlorizin is a competitive inhibitor of SGLT1 and SGLT2; this reduces renal glucose transport, lowering the amount of glucose in the blood.
More Information Supplier PagePI-103 is a potent, cell-permeable, ATP-competitive inhibitor of phosphatidylinositol 3-kinase (PI3K) family members with selectivity toward DNA-PK, PI3K (p110??), and mTOR.
More Information Supplier PagePI-103 is a potent, cell-permeable, ATP-competitive inhibitor of phosphatidylinositol 3-kinase (PI3K) family members with selectivity toward DNA-PK, PI3K (p110??), and mTOR.
More Information Supplier PagePIK-294 is a PI3 Kinase inhibitor that is 20- to 60-fold more potent than the parent compound, PIK-293. It is one of the most potent p110??-selective inhibitors that has been reported.
More Information Supplier PagePIK-294 is a PI3 Kinase inhibitor that is 20- to 60-fold more potent than the parent compound, PIK-293. It is one of the most potent p110??-selective inhibitors that has been reported.
More Information Supplier Page